Get the Stockscreener App
58.93
3.31%
1.89
After Hours:
58.93
Procept Biorobotics Corp stock is traded at $58.93, with a volume of 730.78K.
It is up +3.31% in the last 24 hours and down -0.15% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$57.04
Open:
$57.24
24h Volume:
730.78K
Relative Volume:
0.81
Market Cap:
$3.26B
Revenue:
$249.12M
Net Income/Loss:
$-90.19M
P/E Ratio:
-34.66
EPS:
-1.7
Net Cash Flow:
$-88.21M
1W Performance:
-0.47%
1M Performance:
-0.15%
6M Performance:
-22.48%
1Y Performance:
-17.27%
1-Day Range:
$57.19
$59.50
1-Week Range:
$54.61
$59.50
52-Week Range:
$47.04
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
58.93 | 3.28B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
120.51 | 232.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.65 | 153.66B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.90 | 150.87B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.53 | 114.55B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.18 | 46.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
how procept biorobotics corporation stock performs during market volatilityGroup Only Stock Signals - Newser
Morgan Stanley Lowers PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $68.00 - Defense World
Q2 EPS Estimate for PROCEPT BioRobotics Raised by Analyst - Defense World
Positive Outlook on PROCEPT BioRobotics Amid New Fee Schedule Developments for Aquablation - AInvest
Procept BioRobotics Receives Favorable CMS Updates and Reimbursement Stability - AInvest
Procept BioRobotics says Aquablation therapy assigned a Category I code - MSN
Teacher Retirement System of Texas Has $646,000 Stock Holdings in PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Down 4.7% Following Analyst Downgrade - Defense World
How PROCEPT BioRobotics Corporation stock performs during market volatilityFree Smart Money Stock Analysis - Newser
Why PROCEPT BioRobotics Corporation stock attracts strong analyst attentionPredictable Return Stock Picks - Newser
What makes PROCEPT BioRobotics Corporation stock price move sharplyFree Real-Time Trading Opportunities - Newser
Procept BioRobotics Awarded Category 1 Code in 2026 Medicare Proposal - MarketScreener
Procept BioRobotics stock maintains Buy rating at BofA despite Medicare cuts By Investing.com - Investing.com South Africa
Procept BioRobotics stock maintains Buy rating at BofA despite Medicare cuts - Investing.com
Buy Recommendation for Procept BioRobotics Supported by Favorable CMS Updates and Reimbursement Stability - TipRanks
PROCEPT BioRobotics Announces Category I CPT Code Assignment for Aquablation Therapy Effective January 1, 2026 - Nasdaq
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule - Stock Titan
PROCEPT BioRobotics (NASDAQ:PRCT) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Procept BioRobotics initiated with an Overweight at Stephens - TipRanks
Insiders At PROCEPT BioRobotics Sold US$12m In Stock, Alluding To Potential Weakness - simplywall.st
New Analyst Forecast: $PRCT Given 'Perform' Rating - Quiver Quantitative
Stocks in play: WELL Health Technologies Corp. - The Globe and Mail
Oppenheimer initiates coverage on Procept BioRobotics stock with Perform rating - Investing.com
Allspring Global Investments Holdings LLC Sells 305,956 Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World
Mirae Asset Global Investments Co. Ltd. Purchases 723 Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World
Top Companies in Robotic Surgical Instruments (Jul, 2025) - Tracxn
Positive Outlook for PROCEPT BioRobotics Amid Anticipated CMS Reimbursement and Category 1 Transition - TipRanks
Cork medical firm Healthcare 21 set to introduce new procedure to treat enlarged prostate - Irish Examiner
Procept BioRobotics stock maintains buy rating at Truist on utilization trends - Investing.com
Procept BioRobotics at 2025 Truist Conference: Strategic Growth Path - Investing.com
Rhumbline Advisers Buys 3,077 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
What Makes PROCEPT BioRobotics Corporation (PRCT) an Investment Bet? - Insider Monkey
Robotics Stocks To ResearchJune 5th - MarketBeat
PROCEPT BioRobotics Corp (PRCT) Shares Up 6.15% on Jun 5 - GuruFocus
Procept Biorobotics at Jefferies Conference: Strategic Innovations in BPH Treatment - Investing.com
Procept BioRobotics at 45th Annual William Blair Growth Stock Conference: Aquablation Advances - Investing.com
When (PRCT) Moves Investors should Listen - news.stocktradersdaily.com
PROCEPT BioRobotics Corp (PRCT) Shares Up 5.85% on Jun 3 - GuruFocus
PROCEPT BioRobotics Corp (PRCT) Stock Price Up 3.89% on May 30 - GuruFocus
PROCEPT BioRobotics Corp (PRCT) Stock Price Down 3.29% on May 29 - GuruFocus
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Sold by Ameriprise Financial Inc. - Defense World
Robotics Stocks To Follow TodayMay 18th - MarketBeat
PROCEPT BioRobotics Stock Takes a Breather. Is It a Buy? - Nanalyze
Procept BioRobotics at Bank of America Conference: Strategic Growth Insights - Investing.com
Stock Performance Spotlight: Procept BioRobotics Corp (PRCT) Ends the Day at 53.11, Down by -0.23 - DWinneX
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
PRCTProcept Biorobotics Corp Latest Stock News & Market Updates - Stock Titan
Procept BioRobotics Corp (PRCT) expanding its growth trajectory ahead - Sete News
Ready to Jump After Recent Trade: Incyte Corp (INCY) - Sete News
Leerink Partnrs Has Negative Outlook of PRCT Q2 Earnings - Defense World
Market Insight: Procept BioRobotics Corp (PRCT)’s Notable Drop, Closing at 53.98 - DWinneX
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.67%
0.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):